Figure 4: Prophylactic treatment with B16shR-SOCS1 cells.
(A) Protection against subcutaneous B16F10-Nex2 melanoma in C57Bl/6 mice; (B) increase of C57Bl/6 survival. Two-way ANOVA (**** p < 0.01).
Figure 4: Prophylactic treatment with B16shR-SOCS1 cells. | Scientific Reports
